Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REVERE P KINKEL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1043325939
CMS profile
649351
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$339,350.37

  • Reported across 425 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,967.53

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Biogen, Inc. $6,424.62 9
Amgen Inc. $157.86 3
NOVARTIS PHARMACEUTICALS CORPORATION $138.17 8
TG THERAPEUTICS, INC. $120.97 5
Alexion Pharmaceuticals, Inc. $49.70 2
Genentech USA, Inc. $45.93 2
Celgene Corporation $30.28 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $73,197.57 88
PY2019 $77,799.00 117
PY2020 $67,099.67 52
PY2021 $43,240.16 35
PY2022 $51,426.42 51
PY2023 $19,620.02 52
PY2024 $6,967.53 30

Payment records · PY2024 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $26.29 08/20/2024 Food and Beverage Undisputed 01/23/2026 1093991187 CMS
Alexion Pharmaceuticals, Inc. $23.41 10/02/2024 Food and Beverage Undisputed 01/23/2026 1093998631 CMS
Amgen Inc. $55.00 02/26/2024 Food and Beverage Undisputed 01/23/2026 1115816196 CMS
Amgen Inc. $26.42 07/10/2024 Food and Beverage Undisputed 01/23/2026 1115816204 CMS
Amgen Inc. $76.44 07/26/2024 Food and Beverage Undisputed 01/23/2026 1115816213 CMS
Biogen, Inc. $19.32 01/11/2024 Food and Beverage Undisputed 01/23/2026 1104867018 CMS
Biogen, Inc. $2,055.00 01/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104833421 CMS
Biogen, Inc. $343.00 04/09/2024 Consulting Fee Undisputed 01/23/2026 1104806547 CMS
Biogen, Inc. $171.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1104818768 CMS
Biogen, Inc. $343.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1104870430 CMS
Biogen, Inc. $3,425.00 04/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104832310 CMS
Biogen, Inc. $13.09 04/18/2024 Food and Beverage Undisputed 01/23/2026 1104846360 CMS
Biogen, Inc. $26.72 06/05/2024 Food and Beverage Undisputed 01/23/2026 1104835599 CMS
Biogen, Inc. $28.49 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104860098 CMS
Celgene Corporation $30.28 04/17/2024 Food and Beverage Undisputed 01/23/2026 1101150563 CMS
Genentech USA, Inc. $22.68 04/24/2024 Food and Beverage Undisputed 01/23/2026 1133095510 CMS
Genentech USA, Inc. $23.25 09/25/2024 Food and Beverage Undisputed 01/23/2026 1133095507 CMS
Novartis Pharmaceuticals Corporation $21.75 04/10/2024 Food and Beverage Undisputed 01/23/2026 1087021470 CMS
Novartis Pharmaceuticals Corporation $2.69 05/01/2024 Food and Beverage Undisputed 01/23/2026 1087021474 CMS
Novartis Pharmaceuticals Corporation $18.59 05/22/2024 Food and Beverage Undisputed 01/23/2026 1087021482 CMS
Novartis Pharmaceuticals Corporation $17.20 06/26/2024 Food and Beverage Undisputed 01/23/2026 1087021486 CMS
Novartis Pharmaceuticals Corporation $4.72 07/17/2024 Food and Beverage Undisputed 01/23/2026 1087021490 CMS
Novartis Pharmaceuticals Corporation $25.51 07/24/2024 Food and Beverage Undisputed 01/23/2026 1087021492 CMS
Novartis Pharmaceuticals Corporation $29.29 07/31/2024 Food and Beverage Undisputed 01/23/2026 1087021488 CMS
Novartis Pharmaceuticals Corporation $18.42 10/16/2024 Food and Beverage Undisputed 01/23/2026 1087021510 CMS
TG Therapeutics, Inc. $26.18 01/24/2024 Food and Beverage Undisputed 01/23/2026 1136884670 CMS
TG Therapeutics, Inc. $18.07 04/03/2024 Food and Beverage Undisputed 01/23/2026 1136884690 CMS
TG Therapeutics, Inc. $27.49 05/29/2024 Food and Beverage Undisputed 01/23/2026 1136884698 CMS
TG Therapeutics, Inc. $24.42 06/12/2024 Food and Beverage Undisputed 01/23/2026 1136884692 CMS
TG Therapeutics, Inc. $24.81 07/17/2024 Food and Beverage Undisputed 01/23/2026 1136884756 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.